Sage Journals: Discover world-class research

Abstract

MicroRNAs (miRNAs) regulate gene expression by forming RNA-induced silencing complexes (RISCs) and have been considered as promising therapeutic targets. MiRNA is an essential component of RISC for the modulation of gene expression. Therefore, the release of miRNA from RISC is considered as an effective method for the inhibition of miRNA functions. In our previous study, we reported that anti-miRNA oligonucleotides (AMOs), which are composed of the 2′-O-methyl (2′-OMe) RNA, could induce the release of miRNA from RISC. However, the mechanisms underlying the miRNA-releasing effects of chemically modified AMOs, which are conventionally used as anti-cancer drugs, are still unclear. In this study, we investigated the relationship between the miRNA releasing rate from RISC and the inhibitory effect on RISC activity (IC₅₀) using conventional chemically modified AMOs. We demonstrated that the miRNA-releasing effects of AMOs are directly proportional to the IC₅₀ values, and AMOs, which have an ability to promote the release of miRNA from RISC, can effectively inhibit RISC activity in living cells.

Get full access to this article

View all access options for this article.

References

, Liu

and He

. (2009). microRNAs—powerful repression comes from small RNAs. Sci china Ser C-Life Sci, 52:323–330.

Ambros

. (2004). The functions of animal microRNAs. Nature, 431:350–355.

Kloosterman

and Plasterk

. (2006). The diverse functions of microRNAs in animal development and disease. Cell, 11:441–450.

Bushati

and Cohen

. (2007). microRNA functions. Annu Rev Cell Dev Biol, 23:175–205.

Lima

, Busacca

, Almedia

, Gaudino

, Fennell

and Vasconcelos

. (2011). MicroRNA regulation of core apoptosis pathways in cancer. Eur J Cancer, 47:163–174.

Braun

and Gautel

. (2011). Transcriptional mechanisms regulating skeletal muscle differentiation, growth and homeostasis. Nat Rev Mol Cell Biol, 12:349–361.

Ambros

. (2011). MicroRNAs and developmental timing. Curr Opin Genet Dev, 21:511–517.

Krol

, Leodige

and Filipowicz

. (2010). The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet, 11:597–610.

. (2010). Role of miR-10b in breast cancer metastasis. Breast Cancer Res, 12:210.

10.

Osaki

, Takeshita

and Ochiya

. (2008). MicroRNAs as biomarkers and therapeutic drugs in human cancer. Biomarkers, 13:658–670.

11.

Takamizawa

, Konishi

, Yanagisawa

, Tomida

, Osada

, Endoh

, Harano

, Yatabe

, Nagino

and Takahashi

. (2004). Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res, 64:3753–3756.

12.

Iorio

, Ferracin

, Liu

, Veronese

, Spizzo

, Sabbioni

, Magri

, Pedriali

, Fabbri

, Croce

, et al. (2005). MicroRNA gene expression deregulation in human breast cancer. Cancer Res, 65:7065–7070.

13.

Guo

, Miao

, Xiano

, Huan

, Jiang

, Meng

and Wang

. (2009). Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol, 24:652–657.

14.

and Rana

. (2014). Therapeutic targeting of microRNAs: current status and future challenges. Nat Rev Drug Discov, 13:622–638.

15.

Zhang

, Pan

, Cobb

, and Anderson

. (2007). microRNAs as oncogenes and tumor suppressors. Dev Biol, 302:1–12.

16.

, Thomson

, Hemann

, Hernando-Monge

, Mu

, Goodson and

, Hammond

, et al. (2005). A microRNA polycistron as a potential human oncogene. Nature, 435:828–833.

17.

Esquela-Kerscher

and Slack

. (2006). Oncomirs—microRNAs with a role in cancer. Nat Rev Cancer, 6:259–269.

18.

Shi

, Tepper

and deVere White

. (2008). Cancerous miRNAs and their regulation. Cell Cycle, 7:1529–1538.

19.

Orom

, Kauppinen

and Lund

. (2006). LNA-modified oligonucleotides mediate specific inhibition of microRNA function. Gene, 372:137–141.

20.

Davis

, Lollo

, Freier

and Esau

. (2006). Improved targeting of miRNA with antisense oligonucleotides. Nucleic Acids Res, 34:2294–2304.

21.

Hutvagner

, Simard

, Mello

and Zamore

. (2004). Sequence-specific inhibition of small RNA function. PLoS Biol, 2:465–475.

22.

Inoue

, Hayase

, Imura

, Iwai

, Miura

and Ohtsuka

. (1987). Synthesis and hybridization studies on two complementary nona(2′-O-methyl)ribonucleotides. Nucleic Acids Res, 15:6131–6148.

23.

Sproat

, Lamond

, Beijer

, Neuner

and Ryder

. (1989). Highly efficient chemical synthesis of 2′-O-methyloligoribonucleotides and tetrabiotinylated derivatives; novel probes that are resistant to degradation by RNA or DNA specific nucleases. Nucleic Acids Res, 17:3373–3386.

24.

Lesnik

, Guinosso

, Kawasaki

, Sasmor

, Zounes

, Cummins

, Ecker

, Cook

and Freier

. (1993). Oligodeoxynucleotides containing 2′-O-modified adenosine: synthesis and effects on stability of DNA:RNA duplexes. Biochemistry, 32:7832–7838.

25.

Teplova

, Minasov

, Tereshko

, Inamati

, Cook

, Manoharan

and Egli

. (1999). Crystal structure and improved antisense properties of 2′-O-(2-methoxyethyl)-RNA. Nat Struct Biol, 6:535–539.

26.

Stenvang

, Petri

, Lindow

, Obad

and Kauppinen.

(2012). Inhibition of microRNA function by antimiR oligonucleotides. Silence, 3:1.

27.

Obika

, Nanbu

, Hari

, Morino

, In

, Ishida

and Imanishi

. (1997). Synthesis of 2′-O,4′-C-methyleneuridine and -cytidine. Novel bicyclic nucleosides having a fixed Ca,-endo sugar puckering. Tetrahedron Lett, 38:8735–8738.

28.

Lindow

and Kauppinen

. (2012). Discovering the first microRNA-targeted drug. J Cell Biol, 199:407–412.

29.

Gebert

, Rebhan

, Crivelli

, Denzler

, Stoffel

and Hall

. (2014). Miravirsen (SPC3649) can inhibit the biogenesis of miR-122. Nucleic Acids Res, 42:609–621.

30.

Carthew

and Sontheimer

. (2009). Origins and mechanisms of miRNAs and siRNAs. Cell, 136:642–655.

31.

Huntzinger

and Izaurralde

. (2011). Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet, 12:99–110.

32.

Lin

, Chang

, Chang-Lin

, Lin

, Wu

, Chen

and Ying

. (2008). Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state. RNA, 14:2115–2124.

33.

Ariyoshi

, Momokawa

, Eimori

, Kobori

, Murakami

and Yamayoshi

. (2015). Development of novel antisense oligonucleotides for the functional regulation of RNA-induced silencing complex (RISC) by promoting the release of microRNA from RISC. Bioconjug Chem, 26:2454–2460.

34.

, Young

, Lau

, Meisner

, Morrissey

and MacRae

. (2013). Highly complementary target RNAs promote release of guide RNAs from human Argonaute2. Mol Cell, 50:344–355.

35.

, Shin

, Jung

, Kim

, Song

, and Hohng

. (2015). Human argonaute 2 has diverse reaction pathways on target RNAs. Mol Cell, 59:117–124.

36.

Esau

, Davis

, Murray

, Yu

, Pandey

, Pear

, Watts

, Booten

, Graham

and McKay

, et al. (2006). miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab, 3:87–98.

37.

Krutzfeldt

, Rajewsky

, Braich

, Rajeev

, Tuschl

, Manoharan

and Stoffel

. (2005). Silencing of microRNAs in vivo with ‘antagomirs’. Nature, 438:685–689.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.24 MB

Effective Anti-miRNA Oligonucleotides Show High Releasing Rate of MicroRNA from RNA-Induced Silencing Complex

Abstract

Get full access to this article

References

Supplementary Material